FDA names second participant in TEMPO digital health pilot

The FDA has added Cadence, an AI-enabled hypertension management software company, as the second participant in its TEMPO digital health pilot, allowing participants to collect real-world data through Medicare.

This Wire brief sits within Fusion42's coverage of Digital Health. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.